title: Epidermolysis bullosa: where do we stand?
abstract: Epidermolysis bullosa, a genetically determined skin fragility disorder can severely incapacitate the life of the afflicted patient. Although the clinical features are multiple and varied, treatment still remains a major challenge. There have been major changes in the classification of the disease recently. Although there is still a long way to go, good nursing care, and gene therapy could possibly significantly alleviate the suffering of the patients in the future.
authors: Department of Dermatology and Venereology, Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India. rashmisarka@gmail.com
authors: Rashmi
authors: R
authors: Sarkar
authors: Shuchi
authors: S
authors: Bansal
authors: Vijay Kumar
authors: VK
authors: Garg
mesh_terms: D000818:Animals; D004820:Epidermolysis Bullosa / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D016108:Epidermolysis Bullosa Dystrophica / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D016109:Epidermolysis Bullosa, Junctional / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D005081:Exercise Therapy / Q000639:trends; D015316:Genetic Therapy / Q000639:trends; D006801:Humans